Article: Mild Encephalopathy with Reversible Splenic Lesions in an Infant with COVID-19
Abstract:
There have been few reports of mild encephalopathy with reversible splenic lesions (MERS) associated with COVID-19 in infants. Here, we present a case of MERS in a 23-month-old infant with COVID-19 in Japan during the Omicron variant epidemic. The increase in COVID-19 acute encephalopathy in infants, including those with MERS, should be considered in the future due to the prevalence of the Omicron variant strain. Meanwhile, whether the cause is COVID-19, acute encephalopathy with a lesion localized in the splenium of the corpus callosum can be treated with temporary anticonvulsant therapy, as is generally the case with MERS.
Natsuki Yagi
Department of Paediatrics, Japanese Red Cross Maebashi Hospital, 389-1 Asakuramachi, Maebashi, Gunma 371-0811, Japan
Ryo Sugitate
Department of Paediatrics, Japanese Red Cross Maebashi Hospital, 389-1 Asakuramachi, Maebashi, Gunma 371-0811, Japan
Mariko Shimizu
Department of Paediatrics, Japanese Red Cross Maebashi Hospital, 389-1 Asakuramachi, Maebashi, Gunma 371-0811, Japan
Tomomi Ogata
Department of Paediatrics, Gunma University Graduate School of Medicine, Chome - 39-22 Showamachi, Maebashi, Gunma 371-0034, Japan
Identifier
https://doi.org/10.60086/jnps498
Citation
Collections